NAVB - Navidea Biopharmaceuticals Inc. (NAVB) Q4 2021 Results - Earnings Call Transcript
Navidea Biopharmaceuticals, Inc. (NAVB) Q4 2021 Earnings Conference Call March 23, 2022 17:00 ET Company Participants Michael Rosol - Chief Medical Officer Erika Eves - Vice President, Finance and Administration Conference Call Participants Edward English - Private Investor Presentation Operator Greetings. Welcome to the Navidea Biopharmaceuticals Fourth Quarter Earnings Conference Call. [Operator Instructions] And please note that this conference is being recorded. I will now turn the conference over to Michael Rosol, Chief Medical Officer. Thank you. You may begin. Michael Rosol Thank you and thank you all for joining us today. This call is being webcast live on our website, ir.navidea.com and a replay will be made available. Following prepared remarks, we will be conducting a live Q&A session. Navidea’s Vice President of Finance and Administration, Erika Eves will be joining me on the call today. During the course of this conference call, we will be making forward-looking statements
For further details see:
Navidea Biopharmaceuticals, Inc. (NAVB) Q4 2021 Results - Earnings Call Transcript